Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2018

Oct 3, 2018

30587_dirs_2018-10-03_e64763a1-bf7a-4a62-bb81-c8e5bbafa65e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Urovant Sciences Ltd. (UROV)
CIK: 0001740547
Period of Report: 2018-10-01

Reporting Person: Roivant Sciences Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-10-01 Common Shares, par value $0.000037453 per share P 2678571 $14.00 Acquired 22703669 Direct